Illumina Inc ILMN

NAS: ILMN | ISIN: US4523271090 17/09/2025

100,87 USD (-0,60%)

(-0,60%) 17/09/2025

Grafiek Illumina Inc

Grafiek Illumina Inc

1 dag1d -0,60%
1 week1w 1,57%
1 maand1m 0,34%
3 maanden3m 11,75%
6 maanden6m 18,45%
1 jaar1j -22,98%
5 jaar5j -65,86%

Illumina Inc in het nieuws

Toon enkel gratis nieuws

8 september 2025 · Lancement d'Illumina® Protein Prep pour améliorer les connaissances protéomiques et faciliter les découvertes et le développement de médicaments · Persbericht

3 september 2025 · Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development · Persbericht

31 juli 2025 · Illumina Reports Financial Results for Second Quarter of Fiscal Year 2025 · Persbericht

30 juli 2025 · Illumina enhances flagship assay to accelerate access to comprehensive tumor profiling · Persbericht

10 juli 2025 · Illumina to Announce Second Quarter 2025 Financial Results on Thursday, July 31, 2025 · Persbericht

10 juli 2025 · Illumina named to TIME's World's Most Sustainable Companies list for the second consecutive year · Persbericht

23 juni 2025 · Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy · Persbericht

10 juni 2025 · lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics · Persbericht

29 mei 2025 · Illumina unveils PromoterAI, a groundbreaking algorithm to accelerate insights for rare disease diagnosis · Persbericht

28 mei 2025 · Illumina expands clinical oncology portfolio unlocking new standard of care and access to precision therapies · Persbericht

Profiel Illumina Inc

Gezondheidstechnologie

Productie van analytische laboratoriuminstrumenten

Website: www.illumina.com

Hoofdzetel: San Diego, California Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe